{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:43:02Z","timestamp":1791474182398,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.fct.2005.11.003","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T08:25:47Z","timestamp":1136449547000},"page":"636-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":275,"title":["Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies"],"prefix":"10.1016","volume":"44","author":[{"given":"R.A.","family":"Isbrucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Wolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2005.11.003_bib1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/dmd.30.11.1246","article-title":"Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats","volume":"30","author":"Cai","year":"2002","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.fct.2005.11.003_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/em.10129","article-title":"Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E","volume":"41","author":"Chang","year":"2003","journal-title":"Environmental and Molecular Mutagenesis"},{"key":"10.1016\/j.fct.2005.11.003_bib3","first-page":"1045","article-title":"Absorption, distribution, elimination of tea polyphenols in rats","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.fct.2005.11.003_bib4","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.fct.2005.11.003_bib5","unstructured":"Csato, M., 2001. Ro 26-7624\/000 (Epigallocatechin gallate): study of skin sensitization in the guinea pig; open epicutaneous test. Roche Vitamins Ltd., Report No. 1004123."},{"key":"10.1016\/j.fct.2005.11.003_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/toxsci\/kfh001","article-title":"Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse","volume":"76","author":"Goodin","year":"2003","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.fct.2005.11.003_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408690390826464","article-title":"Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions","volume":"43","author":"Higdon","year":"2003","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/j.fct.2005.11.003_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3835(96)04560-0","article-title":"Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague\u2013Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene","volume":"112","author":"Hirose","year":"1997","journal-title":"Cancer Letters"},{"key":"10.1016\/j.fct.2005.11.003_bib9","first-page":"649","article-title":"Antimutagenic activity of tea: role of polyphenols","volume":"6","author":"Ioannides","year":"2003","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.fct.2005.11.003_bib10","doi-asserted-by":"crossref","unstructured":"Isbrucker, R.A., Bausch, J., Edwards, J.A., Wolz, E., in press. Safety studies on epigallocatechin gallate (EGCG) preparations. 1. Genotoxicity. Food and Chemical Toxicology, doi:10.1016\/j.fct.2005.07.005.","DOI":"10.1016\/j.fct.2005.07.005"},{"key":"10.1016\/j.fct.2005.11.003_bib11","first-page":"57","article-title":"Subchronic oral toxicity of green tea polyphenols in rats and dogs","volume":"48","author":"Johnson","year":"1999","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.fct.2005.11.003_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01635589209514207","article-title":"Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin","volume":"18","author":"Katiyar","year":"1992","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.fct.2005.11.003_bib13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/carcin\/20.11.2117","article-title":"Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production","volume":"20","author":"Katiyar","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fct.2005.11.003_bib14","unstructured":"Kikuoka, N., Yamade, T., Nakatani, H., Matsumoto, H., Takahashi, T., Fujiki, H., 1994. Inhibitory effect of (-)-epigallocatechin gallate, a component of green tea, on the process of chemical carcinogenesis in the glandular stomach mucosa. XVI International Cancer Congress, pp. 1649\u20131653."},{"key":"10.1016\/j.fct.2005.11.003_bib15","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/jn\/133.12.4172","article-title":"Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice","volume":"133","author":"Lambert","year":"2003","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.fct.2005.11.003_bib16","first-page":"393","article-title":"Analysis of plasma and urinary tea polyphenols in human subjects","volume":"4","author":"Lee","year":"1995","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"key":"10.1016\/j.fct.2005.11.003_bib17","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.182429899","article-title":"Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice","volume":"99","author":"Lu","year":"2002","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.fct.2005.11.003_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.1969.42","article-title":"The identification of contact allergens by animal assay. The guinea pig maximization test","volume":"52","author":"Magnusson","year":"1969","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.fct.2005.11.003_bib19","first-page":"57","article-title":"Subchronic oral toxicity of epigallocatechin gallate (EGCG) in rats and dogs","volume":"48","author":"McCormick","year":"1999","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.fct.2005.11.003_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/carcin\/20.3.421","article-title":"Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice","volume":"20","author":"Muto","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fct.2005.11.003_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3177\/jnsv.43.679","article-title":"Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat","volume":"43","author":"Nakagawa","year":"1997","journal-title":"Journal of Nutritional Science and Vitaminology"},{"key":"10.1016\/j.fct.2005.11.003_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1349-7006.1994.tb02085.x","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H\/HeNCrj mice and human hepatoma-derived PLC\/PRF\/5 cells","volume":"85","author":"Nishida","year":"1994","journal-title":"Japanese Journal of Cancer Research"},{"key":"10.1016\/j.fct.2005.11.003_bib23","unstructured":"OECD, 1981. OECD Guideline for Testing of Chemicals\u2014Subchronic Oral Toxicity\u2014Non-rodent: 90-day Study, Guideline No. 409, adopted May, 1981. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib24","unstructured":"OECD, 1987a. OECD Guideline for Testing of Chemicals\u2014Acute Dermal Toxicity, Guideline No. 402, adopted February 1987. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib25","unstructured":"OECD, 1987b. OECD Guideline for Testing of Chemicals\u2014Acute Eye Irritation\/Corroxion, Guideline No. 405, adopted February 1987. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib26","unstructured":"OECD, 1992a. OECD Guideline for Testing of Chemicals\u2014Acute Dermal Irritation\/Corrosion, Guideline No. 404, adopted July, 1992. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib27","unstructured":"OECD, 1992b. OECD Guideline for Testing of Chemicals\u2014Skin Sensitization, Guideline No. 406, adopted July, 1992. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib28","unstructured":"OECD, 1998. OECD Guideline for Testing of Chemicals\u2014Subchronic Oral Toxicity\u2014Rodent: 90-day Study, Guideline No. 408, adopted September 1998. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib29","unstructured":"OECD, 2001. OECD Guideline for Testing of Chemicals\u2014Acute Oral toxicity\u2014Acute Toxic Class Method, Guideline No. 409, adopted December 2001. OECD, Rome, Italy."},{"key":"10.1016\/j.fct.2005.11.003_bib30","unstructured":"Pfannkuch, F., Wolz, E., Barrow, P., Bachmann, M., 2001, Ro 26-7624\/000 (EGCG): 13-week oral (capsules) toxicity study in the beagle dog. Roche Vitamins Ltd., Report No. 1004582."},{"key":"10.1016\/j.fct.2005.11.003_bib31","unstructured":"Pfannkuch, F., Wolz, E., Harder, B.J., Bachmann, M., 2002, Ro 26-7624\/000 (EGCG): 14-day oral (capsule) tolerance study in female Beagle dogs. Roche Vitamins Ltd., Report No. 1007115."},{"key":"10.1016\/j.fct.2005.11.003_bib32","unstructured":"Pfannkuch, F., Wolz, E., Harder, B.J., Bachmann, M., 2003. Ro 26-7624\/000 (EGCG): 13-week oral (capsules) toxicity study in the beagle dog. Roche Vitamins Ltd., Report No. 1009351."},{"key":"10.1016\/j.fct.2005.11.003_bib33","unstructured":"Pfannkuch, F., Wolz, E., Johnson, W.D., McCormick, D.L. 2000, Ro 26-7624\/000 (EGCG): 13-week oral (dietary) toxicity study in rats. Roche Vitamins Ltd., Report No. B-172\u2019301."},{"key":"10.1016\/j.fct.2005.11.003_bib34","first-page":"483","article-title":"Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study","volume":"15","author":"Sasazuki","year":"2004","journal-title":"Cancer Causes and Control"},{"key":"10.1016\/j.fct.2005.11.003_bib35","unstructured":"Schlaeppi, B., Pfannkuch, F., 2001. Ro 26-7624\/000 (EGCG): Exploratory study in femal Beagle dogs by daily oral capsule. Roche Vitamins Ltd., Report No. B-1005917."},{"key":"10.1016\/j.fct.2005.11.003_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.fct.2004.11.001","article-title":"Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture","volume":"43","author":"Schmidt","year":"2005","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.fct.2005.11.003_bib37","first-page":"834","article-title":"Y a-t-il des risques d\u2019h\u00e9patotoxicit\u00e9 avec Exolise\u00ae? [Is Exolise hepatotoxic?]","volume":"25","author":"Seddik","year":"2001","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1016\/j.fct.2005.11.003_bib38","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1378\/chest.106.6.1801","article-title":"Epigallocatechin gallate. The major causative agent of green tea-induced asthma","volume":"106","author":"Shirai","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.fct.2005.11.003_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1081-1206(10)63087-6","article-title":"Epigallocatechin gallate-induced histamine release in patients with green tea-induced asthma","volume":"79","author":"Shirai","year":"1997","journal-title":"Annals of Allergy, Asthma and Immunology"},{"key":"10.1016\/j.fct.2005.11.003_bib40","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1046\/j.1365-2222.2003.01744.x","article-title":"Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness","volume":"33","author":"Shirai","year":"2003","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.fct.2005.11.003_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(00)00498-5","article-title":"Dermal toxicity of topical (-)-epigallocatechin-3-gallate in BALB\/c and SKH1 mice","volume":"158","author":"Stratton","year":"2000","journal-title":"Cancer Letters"},{"key":"10.1016\/j.fct.2005.11.003_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A single ascending dose study of epigallocatechin gallate in healthy volunteers","volume":"31","author":"Ullmann","year":"2003","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/j.fct.2005.11.003_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1024\/0300-9831.74.4.269","article-title":"Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers","volume":"74","author":"Ullmann","year":"2004","journal-title":"International Journal for Vitamin and Nutrition Research"},{"key":"10.1016\/j.fct.2005.11.003_bib44","first-page":"1166","article-title":"H\u00e9patite aigu\u00eb imputable \u00e0 l\u2019Exolise\u00ae (Camellia sinensis) [Acute hepatitis due to Exolise, a Camellia sinensis-derived drug]","volume":"27","author":"Vial","year":"2003","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1016\/j.fct.2005.11.003_bib45","unstructured":"Wolz, E., Pfannkuch, F., Straub, J., van Huygevoort, A.H.B.M., 2001a. Assessment of acute oral toxicity with Ro 26-7624\/000 (EGCG) in the rat (acute toxic class method). Roche Vitamins Ltd., Report No. 1004023."},{"key":"10.1016\/j.fct.2005.11.003_bib46","unstructured":"Wolz, E., Pfannkuch, F., Straub, J., van Huygevoort, A.H.B.M., 2001b. Assessment of contact hypersensitivity to Ro 26-7624\/000 (EGCG) in the albino guinea pig (maximisation test). Roche Vitamins Ltd., Report No. 1004024."},{"key":"10.1016\/j.fct.2005.11.003_bib47","unstructured":"Wolz, E., Pfannkuch, F., Straub, J., van Huygevoort, A.H.B.M., 2001c. Primary skin irritation\/corrosion study with Ro 26-7624\/000 (EGCG) in the rabbit (4-h semi-occlusive application). Roche Vitamins Ltd., Report No. 1004025."},{"key":"10.1016\/j.fct.2005.11.003_bib48","unstructured":"Wolz, E., Scheidegger, C., Arcelin, G., 2002a. Teavigo: Acute dermal toxicity study in rats. Roche Vitamins Ltd., Report No. 1010389."},{"key":"10.1016\/j.fct.2005.11.003_bib49","unstructured":"Wolz, E., Scheidegger, C., Arcelin, G., 2002b. Teavigo: Primary eye irritation study in rabbits. Roche Vitamins Ltd., Report No. 1010390."},{"key":"10.1016\/j.fct.2005.11.003_bib50","first-page":"2081","article-title":"Inhibition of N-methyl-N\u2032-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach","volume":"55","author":"Yamane","year":"1995","journal-title":"Cancer Research"},{"key":"10.1016\/j.fct.2005.11.003_bib51","first-page":"713","article-title":"Tea consumption and ovarian cancer risk: a case-control study in China","volume":"11","author":"Zhang","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691505003340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691505003340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:37:19Z","timestamp":1759523839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691505003340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0278691505003340"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2005.11.003","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2005.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}